Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Current Medicinal Chemistry
|
September 14, 2017
Recent Advances in Cancer Drug Development: Targeting Induced Myeloid Cell Leukemia-1 (Mcl-1) Differentiation Protein
Mohammad Abid, Yogesh A Sonawane, Jacob I Contreras, et al.
Journal of Medicinal Chemistry
|
May 13, 2016
Cyclin Dependent Kinase 9 Inhibitors for Cancer Therapy
Yogesh A Sonawane, Margaret A Taylor, John Victor Napoleon, et al.
Macromolecular Bioscience
|
May 17, 2017
Developing Polyamine-Based Peptide Amphiphiles with Tunable Morphology and Physicochemical Properties
Mehdi Bin Samad, Yashpal Singh Chhonker, Jacob I Contreras, et al.
Chemical Biology & Drug Design
|
April 3, 2020
Symbiotic prodrugs (SymProDs) dual targeting of NFkappaB and CDK
Sandeep Rana, Smit Kour, Yogesh A Sonawane, et al.
Chemical Communications (Cambridge, England)
|
June 22, 2017
Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC)
Caroline M Robb, Jacob I Contreras, Smit Kour, et al.
Oncotarget
|
April 15, 2017
Discovery and characterization of small molecule Rac1 inhibitors
Jamie L Arnst, Ashley L Hein, Margaret A Taylor, et al.
Journal of Medicinal Chemistry
|
April 15, 2016
Isatin Derived Spirocyclic Analogues with α-Methylene-γ-butyrolactone as Anticancer Agents: A Structure-Activity Relationship Study
Sandeep Rana, Elizabeth C Blowers, Calvin Tebbe, et al.
ACS Chemical Biology
|
April 3, 2018
Chemical Genetic Screens Identify Kinase Inhibitor Combinations that Target Anti-Apoptotic Proteins for Cancer Therapy
Jacob I Contreras, Caroline M Robb, Hannah M King, et al.
European Journal of Medicinal Chemistry
|
June 7, 2021
Structure activity relationship (SAR) study identifies a quinoxaline urea analog that modulates IKKβ phosphorylation for pancreatic cancer therapy
Satish Sagar, Sarbjit Singh, Jayapal Reddy Mallareddy, et al.
Molecular Pharmacology
|
August 31, 2019
CDK5 Inhibitor Downregulates Mcl-1 and Sensitizes Pancreatic Cancer Cell Lines to Navitoclax
Smit Kour, Sandeep Rana, Jacob I Contreras, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Current Medicinal Chemistry
|
September 14, 2017
Recent Advances in Cancer Drug Development: Targeting Induced Myeloid Cell Leukemia-1 (Mcl-1) Differentiation Protein
Mohammad Abid, Yogesh A Sonawane, Jacob I Contreras, et al.
Journal of Medicinal Chemistry
|
May 13, 2016
Cyclin Dependent Kinase 9 Inhibitors for Cancer Therapy
Yogesh A Sonawane, Margaret A Taylor, John Victor Napoleon, et al.
Macromolecular Bioscience
|
May 17, 2017
Developing Polyamine-Based Peptide Amphiphiles with Tunable Morphology and Physicochemical Properties
Mehdi Bin Samad, Yashpal Singh Chhonker, Jacob I Contreras, et al.
Chemical Biology & Drug Design
|
April 3, 2020
Symbiotic prodrugs (SymProDs) dual targeting of NFkappaB and CDK
Sandeep Rana, Smit Kour, Yogesh A Sonawane, et al.
Chemical Communications (Cambridge, England)
|
June 22, 2017
Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC)
Caroline M Robb, Jacob I Contreras, Smit Kour, et al.
Oncotarget
|
April 15, 2017
Discovery and characterization of small molecule Rac1 inhibitors
Jamie L Arnst, Ashley L Hein, Margaret A Taylor, et al.
Journal of Medicinal Chemistry
|
April 15, 2016
Isatin Derived Spirocyclic Analogues with α-Methylene-γ-butyrolactone as Anticancer Agents: A Structure-Activity Relationship Study
Sandeep Rana, Elizabeth C Blowers, Calvin Tebbe, et al.
ACS Chemical Biology
|
April 3, 2018
Chemical Genetic Screens Identify Kinase Inhibitor Combinations that Target Anti-Apoptotic Proteins for Cancer Therapy
Jacob I Contreras, Caroline M Robb, Hannah M King, et al.
European Journal of Medicinal Chemistry
|
June 7, 2021
Structure activity relationship (SAR) study identifies a quinoxaline urea analog that modulates IKKβ phosphorylation for pancreatic cancer therapy
Satish Sagar, Sarbjit Singh, Jayapal Reddy Mallareddy, et al.
Molecular Pharmacology
|
August 31, 2019
CDK5 Inhibitor Downregulates Mcl-1 and Sensitizes Pancreatic Cancer Cell Lines to Navitoclax
Smit Kour, Sandeep Rana, Jacob I Contreras, et al.
Page
of 2